SOURCE: NaturalNano, Inc.

October 28, 2014 08:55 ET

NaturalNano Establishes ViralProtec Division to Supply Personal Protective Equipment for Caregivers in Fight Against Ebola and Other Infectious Diseases

ViralProtec Announces Purchase Order With California Hospital

ROCHESTER, NY--(Marketwired - Oct 28, 2014) - NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced today the formation of its ViralProtec Division (www.viralprotec.com) to service the growing demand for Personal Protective Equipment (PPE). The recent public concern and publicity surrounding the increased risk to caregivers and other responders created by the Ebola virus as well as other public health concerns has raised awareness of the need for additional precautionary steps for those dealing with these issues.

ViralProtec sells a range of personal protection equipment (PPE) including complete PPE suits which comprise of chemical protective suits, aprons, boots, gloves and a 3M Versaflo Powered Air Purifying Respirator Systems (PAPR). The Company has received a number of inquiries and orders.

Jim Wemett, CEO of NaturalNano, stated, "The Center for Disease and Control and Prevention has revised Ebola Gear Guidelines stating the need to be covered from head to toe with full protective clothing. In entering this strategic business line we recognized that it is very difficult to source a complete PPE solution from a single source. Our goal in launching ViralProtec is to fill that void in the market, and to date the response from the market place and potential customers has been remarkable." Wemett continued, "By carrying a full line of protective gear and isolation chambers we will provide a valuable offering that can assist in making our health workers' environment as safe as possible."

About ViralProtec

ViralProtec (www.viralprotec.com) a wholly owned subsidiary of NaturalNano, is a reseller for best practices Ebola personal protective equipment (PPE) and ancillary supplies. Our mission is to provide personal protective equipment for patient care of those at risk during infectious disease patient care that meet or exceed CDC and WHO guidelines.

NaturalNano, Inc. (PINKSHEETS: NNAN) located in Rochester, New York, is engaged in the development and commercialization of material additives based on proprietary nanomaterial technology utilizing Halloysite Nanotubes (HNTs). For more information please visit www.naturalnano.com.

Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports filed with the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.

Contact Information